SCHEMBL24310026

SCHEMBL24310026

CCc1c(Oc2ccc(N3CCNCC3)cc2)nc(NSc2cnn(C)c2)nc1-c1c(C)cc(C)cc1C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACVR1 Q04771 4/20 0.32
▸ LCK P06239 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ BTK Q06187 1/20 0.32
▸ TNK2 Q07912 1/20 0.32
▸ LTA4H P09960 4/20 0.31
▸ BMPR1B O00238 1/20 0.31
▸ BMPR1A P36894 1/20 0.31
▸ ACVRL1 P37023 1/20 0.31
▸ AXL P30530 1/20 0.31
▸ MERTK Q12866 1/20 0.31
▸ RET P07949 1/20 0.31
▸ CCNB2 O95067 1/20 0.30
▸ CCNE2 O96020 1/20 0.30
▸ CDK1 P06493 1/20 0.30
▸ CDK4 P11802 1/20 0.30
▸ CCNB1 P14635 1/20 0.30
▸ CCNA2 P20248 1/20 0.30
▸ CCND1 P24385 1/20 0.30
▸ CCNE1 P24864 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309498 0.92 ACVR1 (0.32) ACVR1LCKJAK3BTKTNK2
SCHEMBL24310025 0.86 TNK2 (0.35) ACVR1LCKJAK3BTKTNK2
SCHEMBL24310019 0.85 LTA4H (0.39) ACVR1LCKJAK3BTKTNK2
SCHEMBL29566401 0.84 NOD2 (0.36) ACVR1LCKJAK3BTKTNK2
SCHEMBL24310021 0.84 NOD2 (0.36) ACVR1LCKJAK3BTKTNK2
SCHEMBL24310046 0.83 LTA4H (0.34) ACVR1LCKJAK3BTKTNK2
SCHEMBL24309516 0.82 FLT3 (0.35) ACVR1LTA4HBMPR1BBMPR1AACVRL1
SCHEMBL24310033 0.81 LTA4H (0.32) ACVR1LCKJAK3BTKTNK2
SCHEMBL24309866 0.80 FLT3 (0.36) ACVR1LTA4HBMPR1BBMPR1AACVRL1
SCHEMBL24309744 0.79 LTA4H (0.38) ACVR1LCKJAK3BTKTNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback